Literature DB >> 10880969

Specific Ser-Pro phosphorylation by the RNA-recognition motif containing kinase KIS.

A Maucuer1, J P Le Caer, V Manceau, A Sobel.   

Abstract

We present here a first appraisal of the phosphorylation site specificity of KIS (for 'kinase interacting with stathmin'), a novel mammalian kinase that has the unique feature among kinases to possess an RNP type RNA-recognition motif (RRM). In vitro kinase assays using various standard substrates revealed that KIS has a narrow specificity, with myelin basic protein (MBP) and synapsin I being the best in vitro substrates among those tested. Mass spectrometry and peptide sequencing allowed us to identify serine 164 of MBP as the unique site phosphorylated by KIS. Phosphorylation of synthetic peptides indicated the importance of the proline residue at position +1. We also identified a tryptic peptide of synapsin I phosphorylated by KIS and containing a phosphorylatable Ser-Pro motif. Altogether, our results suggest that KIS preferentially phosphorylates proline directed residues but has a specificity different from that of MAP kinases and cdks.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880969     DOI: 10.1046/j.1432-1327.2000.01493.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

Review 1.  U2AF homology motifs: protein recognition in the RRM world.

Authors:  Clara L Kielkopf; Stephan Lücke; Michael R Green
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

2.  Protein kinase KIS localizes to RNA granules and enhances local translation.

Authors:  Serafí Cambray; Neus Pedraza; Marta Rafel; Eloi Garí; Martí Aldea; Carme Gallego
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

3.  The myristoylated alanine-rich C kinase substrate differentially regulates kinase interacting with stathmin in vascular smooth muscle and endothelial cells and potentiates intimal hyperplasia formation.

Authors:  Dan Yu; Ramkishore Gernapudi; Charles Drucker; Rajabrata Sarkar; Areck Ucuzian; Thomas S Monahan
Journal:  J Vasc Surg       Date:  2019-03-28       Impact factor: 4.268

4.  Cancer-relevant splicing factor CAPERα engages the essential splicing factor SF3b155 in a specific ternary complex.

Authors:  Sarah Loerch; Alexandre Maucuer; Valérie Manceau; Michael R Green; Clara L Kielkopf
Journal:  J Biol Chem       Date:  2014-05-02       Impact factor: 5.157

5.  SF1 Phosphorylation Enhances Specific Binding to U2AF65 and Reduces Binding to 3'-Splice-Site RNA.

Authors:  Rakesh Chatrikhi; Wenhua Wang; Ankit Gupta; Sarah Loerch; Alexandre Maucuer; Clara L Kielkopf
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

6.  Signaling from the secretory granule to the nucleus: Uhmk1 and PAM.

Authors:  Victor P Francone; Marius F Ifrim; Chitra Rajagopal; Christopher J Leddy; Yanping Wang; John H Carson; Richard E Mains; Betty A Eipper
Journal:  Mol Endocrinol       Date:  2010-06-23

7.  The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.

Authors:  Y L Woods; P Cohen; W Becker; R Jakes; M Goedert; X Wang; C G Proud
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

8.  Structure of phosphorylated SF1 bound to U2AF⁶⁵ in an essential splicing factor complex.

Authors:  Wenhua Wang; Alexandre Maucuer; Ankit Gupta; Valérie Manceau; Karen R Thickman; William J Bauer; Scott D Kennedy; Joseph E Wedekind; Michael R Green; Clara L Kielkopf
Journal:  Structure       Date:  2012-12-27       Impact factor: 5.006

9.  Different requirements of the kinase and UHM domains of KIS for its nuclear localization and binding to splicing factors.

Authors:  Valérie Manceau; Clara L Kielkopf; André Sobel; Alexandre Maucuer
Journal:  J Mol Biol       Date:  2008-06-17       Impact factor: 5.469

10.  A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.

Authors:  Manfred Boehm; Takanobu Yoshimoto; Martin F Crook; Shriram Nallamshetty; Andrea True; Gary J Nabel; Elizabeth G Nabel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.